Dr. Khalid Mohamed Moussa, MD

Dr. Moussa practices at North Okaloosa Medical Center in Crestview, Florida, part of Community Health Systems.

Dr. Moussa's NPI, 1922116631, was assigned on August 25, 2006. Dr. Moussa graduated from University of Tripoli School of Medicine in 1984. Dr. Moussa holds Florida license ME100573.

Dr. Moussa's primary practice is North Okaloosa Medical Center, at 151 Redstone Ave SE, Crestview, FL 32539 in Okaloosa County. The practice phone is (850) 689-8100.

Dr. Moussa's primary practice is North Okaloosa Medical Center in Crestview, Florida, part of Community Health Systems. Dr. Moussa is also affiliated with Ascension Sacred Heart Pensacola. Dmand AI also links Dr. Moussa to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moussa practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Moussa's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Moussa is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Moussa's licenses on file in 4 states: Florida, Louisiana, Connecticut and Massachusetts.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, esophagus, stomach, or upper small intestine surgery and gastroduodenitis among the conditions Dr. Moussa treats.

CMS data shows 2,454 Medicare services from Dr. Moussa across 17 procedure codes in 2024, for 480 Medicare patients. Medicare paid $207,389 for them.

CMS counts 480 Medicare patients who saw Dr. Moussa in 2024. The largest group is 75 to 84, with 173 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moussa's median patient age at 66, with 55% women.

In 2024, Dr. Moussa wrote 752 Medicare Part D claims for 162 patients. 85% of them were for generic drugs. CMS names the drug for 593 of them, across 17 drugs with 11 or more claims each, at $88,983 in total drug cost. In 2023, CMS named 530 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Moussa for performance year 2024, reported individually. Dr. Moussa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 306 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Moussa, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Moussa. Dr. Moussa's most frequent co-author is David N. Bailey, MD.

CMS Open Payments shows 202 general payments to Dr. Moussa from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,404.

Dr. Moussa graduated from University of Tripoli School of Medicine in 1984.

Dr. Moussa is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.